Latest filing published 16 Sept 2019 for Immunovia AB, €1,305.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Hans Liljenborg: trading record in brief
Hans Liljenborg discloses dealings in Immunovia AB to Finansinspektionen. We count 4 filings; the first trade dates from 6 July 2016 and the latest from 12 September 2019.
Every open-market trade on record is a purchase: 4 purchases worth €444k, and no sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. In 2019 alone, the filings show 2 purchases and no sales.
The median purchase comes to €2,491.
Most recently, on 16 September 2019, the filings show an open-market purchase worth €1,305 in Immunovia AB. Filings reach the Finansinspektionen feed a median of 4 days after the trade. For comparison, MAR article 19 gives managers three business days to notify a trade. Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Hans Liljenborg
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,000 shares@ SEK 6.950.1% of flowTeckningsoptionFI:csv-e726154eeed19a5db216Canonical exit: 11 Dec 2019 (T+90)
- 5,000 shares@ SEK 7.770.3% of flowTeckningsoptionFI:csv-51eacc09e1ca06b15b77Canonical exit: 28 Sept 2019 (T+90)
- 40 shares@ SEK 87.000.0% of flowISIN SE0009155336FI:csv-3583a7bf20be24e65499Canonical exit: 2 Jan 2017 (T+90)
- 50,000 shares@ SEK 83.0033.6% of flowFI:csv-cee5a93bddbc63c23871Canonical exit: 4 Oct 2016 (T+90)
4 of 4 declarations